HealthEquity, Inc. (HQY) administers health savings accounts and complementary consumer-directed benefits for employers, benefits advisors, health plans, retirement plan providers, and healthcare consumers. Company updates commonly cover HSA account growth, HSA assets, service, custodial and interchange revenue, guidance, margin measures, stock repurchases, and actions to manage HSA cash repricing exposure.
News also includes board and executive governance changes, investor conference participation, research on healthcare affordability and HSA adoption, and product or platform themes tied to helping members save, spend and invest for healthcare.
HealthEquity (NASDAQ: HQY) reported record fourth-quarter sales and strong fiscal 2026 metrics. HSAs reached 10.6 million (+7%), Total Accounts 17.8 million (+4%), HSA Assets $36.5B (+14%) and HSA investments $18.5B (+26%).
The company reaffirmed fiscal 2026 guidance (near top of prior ranges) and will provide updated fiscal 2027 guidance with March results. Management set its Q4/fiscal 2026 earnings call for March 17, 2026.
HealthEquity (NASDAQ: HQY) provided its initial fiscal 2027 outlook and will present the details at the J.P. Morgan Healthcare Conference on Jan 13, 2026 at 3:00 pm PT. Management expects FY2027 revenue of $1.38B–$1.41B, Adjusted EBITDA margin of 43.8%–44.3%, and a yield on HSA Cash of ~3.75%. The company also reaffirmed previously provided guidance for fiscal 2026. Executives presenting include CEO Scott Cutler, Vice Chair and Founder Steve Neeleman, and EVP/CFO James Lucania. A live audio webcast and presentation slides will be available and archived on the company investor relations website.
HealthEquity (NASDAQ: HQY) released its inaugural Fall 2025 Healthcare Affordability Pulse surveying 618 employed Americans between June 25 and July 9, 2025. The results show a generational divide: 56% of Gen Z and 50% of Millennials have HSAs versus 35% Gen X and 24% Boomers. Younger workers report higher benefits understanding (Gen Z 53%, Millennials 62%) but greater economic anxiety (Gen Z 84%) and workplace distraction from finances. HSA holders generally show stronger preparedness for routine care (52% vs 46%), larger emergency reserves (29% with ≥$5,000 vs 25%), and are less likely to cut critical care. HealthEquity links education and employer support to improved financial wellbeing.
HealthEquity (NASDAQ: HQY) reported third-quarter fiscal 2026 results for the period ended October 31, 2025, with revenue of $322.2 million (up 7% year‑over‑year) and net income of $51.7 million ($0.59 per diluted share).
Key operating metrics: Adjusted EBITDA $141.8 million (44% of revenue, +20% YoY), non‑GAAP net income per diluted share $1.01 (+29% YoY), 10.1 million HSAs (+6% YoY) and Total HSA Assets $34.4 billion (+15% YoY). The company repurchased 1.0 million shares for $93.7 million and maintains $258.8 million remaining repurchase authorization. FY26 guidance: revenue $1.302B–$1.312B; non‑GAAP net income per share $3.87–$3.95.
HealthEquity (Nasdaq: HQY) announced it will deploy agentic AI built with Parloa to deliver conversational, action‑oriented member support across voice, mobile app chat, and web starting with a limited release in November 2025 and expanding through 2026. The system preserves context across turns, blends automated actions with human escalation, and builds on existing AI tools including an Expedited Claims AI that saves members an average of 70% of claims-entry time with more than half processed in under two minutes, plus HSAnswers and HealthEquity Assist™ suites. HealthEquity positions the rollout as a phased, measured deployment to refine member experience before full scale.
HealthEquity (NASDAQ: HQY) will release third quarter fiscal 2026 results after market close on Wednesday, December 3, 2025. Management will host a conference call the same day at 4:30 p.m. Eastern Time (2:30 p.m. Mountain Time) to review results. Investors can join by phone (US/Canada: 1-833-630-1956; International: 1-412-317-1837) or via webcast at ir.healthequity.com. A replay will be available on the company website following the call.
HealthEquity (Nasdaq: HQY) on Oct 14, 2025 launched two consumer offerings: a curated GLP-1 telehealth platform (live today) that enables HSA payment for weight-management medications via a partnership with Agile Telehealth, and a direct HSA enrollment platform integrated into its mobile and web channels.
Key facts: HSA assets reached nearly $147 billion across >39 million accounts by year-end 2024, with members spending $42 billion in 2024 (up 10% vs 2023). Regulatory changes qualifying Bronze plans for HSAs beginning 2026 create eligibility for >7 million newly eligible Americans.
HealthEquity (NASDAQ: HQY), the largest HSA and consumer-directed benefits administrator in the US, has announced two strategic executive appointments to capitalize on significant market expansion opportunities. Mukund Ramachandran joins as Chief Marketing Officer from Mastercard, while Garett Kitch becomes SVP of Client Sales & Relationship Management from EverQuote.
The appointments coincide with the largest HSA eligibility expansion in 20 years, which will allow Direct Primary Care arrangements, telehealth services, and Bronze/Catastrophic ACA plans to be coupled with HSAs starting January 2026. This expansion opens up opportunities with over 7M people currently enrolled in bronze plans, of which approximately 90% were previously HSA-ineligible.
The company continues advancing its AI-powered solutions, including automated claims processing, with its Member First Secure Mobile Experience reaching 1.7M downloads.
HealthEquity (NASDAQ: HQY), the largest HSA custodian in the US, reported strong Q2 FY26 financial results. Revenue reached $325.8 million, up 9% year-over-year, while net income surged 67% to $59.9 million. The company achieved record gross margin of 71% and Adjusted EBITDA of $151.1 million, representing 46% of revenue.
Key metrics include 10.0 million HSAs (up 6% YoY) and Total HSA Assets of $33.1 billion (up 12% YoY). The company repurchased 0.7 million shares for $66.0 million. For FY26, HealthEquity projects revenue between $1.290-1.310 billion and Adjusted EBITDA of $540-560 million.
HealthEquity (Nasdaq: HQY), the largest HSA and consumer-directed benefits administrator in the US, has received multiple prestigious awards for its AI-powered educational tool HSAnswers. Launched in October 2024, the tool has won the 2025 AI Breakthrough Award for Informational Bot Solution of the Year and two Globee Silver Awards.
HSAnswers leverages over 500 educational resources and 20 years of industry expertise to provide instant, personalized answers about HSAs and other consumer-directed benefits. The tool addresses a critical market need, as 73% of employees seek improved benefits education. Available freely at healthequity.com/hsanswers, the platform has already facilitated hundreds of thousands of conversations since launch.